PetVivo Holdings, Inc. (NASDAQ: PETV, PETVW) (the "Company" or
“PetVivo”) an emerging biomedical device company focused on the
commercialization of innovative medical devices and therapeutics
for companion animals, today announced that it has begun the
application process to dual list its shares on Upstream, the
revolutionary trading app for digital securities and NFTs powered
by Horizon Fintex (“Horizon”) and MERJ Exchange Limited (“MERJ”).
The planned dual listing on Upstream is designed
to provide the Company the opportunity to access a global,
digital-first investor base that can trade using USDC digital
currency along with credit, debit, PayPal, and USD, unlocking
liquidity and enhancing price discovery while globalizing the
opportunity to invest in NASDAQ-listed PetVivo.
“We are always looking for ways to provide
greater liquidity and value to our shareholders,” said John Lai,
Chief Executive Officer of PetVivo Holdings, Inc. “We see a dual
listing on Upstream as being an excellent way to reach a worldwide
market of potential new investors who can learn about our
Company.”
Approval to be listed on Upstream is subject to
approval by MERJ. However as a current Nasdaq issuer PetVivo may be
eligible for an expedited listing process.
About Upstream
Upstream, a MERJ Exchange Market (MERJ
Exchange), is a fully regulated global stock exchange for digital
securities and NFTs. Powered by Horizon's Ethereum-L2 matching
engine technology, the platform enables users to trade NFTs, and
invest in securities for IPOs, crowdfunded companies, U.S. &
international equities, and celebrity ventures using the Upstream
app. For more information, please visit https://upstream.exchange.
Upstream is currently accepting applications to dual list at
https://upstream.exchange/GetListed.
About PetVivo Holdings,
Inc.
PetVivo Holdings Inc. (NASDAQ: PETV & PETVW)
is an emerging biomedical device company currently focused on the
manufacturing, commercialization and licensing of innovative
medical devices and therapeutics for companion animals. The
Company's strategy is to leverage human therapies for the treatment
of companion animals in a capital and time efficient way. A key
component of this strategy is the accelerated timeline to revenues
for veterinary medical devices, which enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for
the treatment of animals and people. A portfolio of nineteen
patents protects the Company's biomaterials, products, production
processes and methods of use. The Company’s lead product SPRYNG™
with OsteoCushion™ technology, a veterinarian-administered,
intraarticular injection for the management of lameness and other
joint related afflictions, including osteoarthritis, in dogs and
horses, is currently available for commercial sale.
For more information about PetVivo Holdings,
Inc. and our revolutionary product, Spryng with OsteoCushion
Technology, please contact info1@petvivo.com or visit
https://petvivo.com/
CONTACT:
John Lai, CEOPetVivo Holdings, Inc.Email:
info1@petvivo.com(952) 405-6216
Forward-Looking Statements:
The foregoing material may contain
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, each as amended. Forward-looking statements
include all statements that do not relate solely to historical or
current facts, including without limitation the Company’s proposed
development and commercial timelines, and can be identified by the
use of words such as “may,” “will,” “expect,” “project,”
“estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,”
“continue” or the negative versions of those words or other
comparable words. Forward-looking statements are not guarantees of
future actions or performance. These forward-looking statements are
based on information currently available to the Company and its
current plans or expectations and are subject to a number of
uncertainties and risks that could significantly affect current
plans. Risks concerning the Company’s business are described in
detail in the Company’s Annual Report on Form 10-K for the year
ended March 31, 2022 and other periodic and current reports filed
with the Securities and Exchange Commission. The Company is under
no obligation to, and expressly disclaims any such obligation to,
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
Disclaimers:
This press release shall not constitute an offer
to sell securities or the solicitation of an offer to buy
securities in any jurisdiction where such offer or solicitation is
not permitted.
NFTs received have no economic value, royalties,
equity ownership, or dividends. NFTs are for utility, collection,
and display only.
*U.S. investors are not permitted to purchase
Upstream listed securities. U.S. and Canadian citizens will only be
able to trade in securities they currently own, that have been
listed on Upstream, for liquidation purposes only.
If funding Upstream with an ACH or wire bank
payment, users must complete Upstream's in-app KYC process to get
their new, FDIC insured, Upstream U.S. bank account details via
email. Users may then initiate a funds-transfer from their bank or
financial institution to this new U.S. Dollar bank account. If you
haven't completed KYC yet, or didn't select ‘Bank' as the ‘Deposit
From' option when you completed the process initially, then please
go through KYC again selecting the ‘Bank' payment method. Users may
complete the simple KYC process by tapping the settings icon and
the KYC option inside the Upstream app.
Upstream is a MERJ Exchange market. MERJ
Exchange is a licensed Securities Exchange, an affiliate of the
World Federation of Exchanges, and a full member of ANNA. MERJ
supports global issuers of traditional and digital securities
through the entire asset life cycle from issuance to trading,
clearing, settlement, and registry. It operates a fair and
transparent marketplace in line with international best practices
and principles of operations of financial markets. Upstream does
not endorse or recommend any public or private securities bought or
sold on its app. Upstream does not offer investment advice or
recommendations of any kind. All services offered by Upstream are
intended for self-directed clients who make their own investment
decisions without aid or assistance from Upstream. All customers
are subject to the rules and regulations of their jurisdiction. By
accessing the site or app, you agreed to be bound by its terms of
use and privacy policy. Company and security listings on Upstream
are only suitable for investors who are familiar with and willing
to accept the high risk associated with speculative investments,
often in early and development stage companies. There can be no
assurance the valuation of any particular company's securities is
accurate or in agreement with the market or industry comparative
valuations. Investors must be able to afford market volatility and
afford the loss of their investment. Companies listed on Upstream
are subject to significant ongoing corporate obligations including,
but not limited to disclosure, filings, and notification
requirements, as well as compliance with applicable quantitative
and qualitative listing standards.
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Jul 2024 to Jul 2024
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Jul 2023 to Jul 2024